SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sarah Kattakuzhy, Rachel Levy, Shyam Kottilil, Sofosbuvir for treatment of chronic hepatitis C, Hepatology International, 2015, 9, 2, 161

    CrossRef

  2. 2
    Robert Cheng, Thomas Tu, Nicholas Shackel, Geoffrey W McCaughan, Advances in and the future of treatments for hepatitis C, Expert Review of Gastroenterology & Hepatology, 2014, 8, 6, 633

    CrossRef

  3. 3
    Margaret E Hellard, Joseph S Doyle, Interferon-free hepatitis C treatment: one pill to fit all?, The Lancet, 2014, 383, 9916, 491

    CrossRef

  4. 4
    Ivan Gentile, Nicola Coppola, Antonio Riccardo Buonomo, Emanuela Zappulo, Guglielmo Borgia, Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus, Expert Opinion on Investigational Drugs, 2014, 23, 9, 1211

    CrossRef

  5. 5
    Benjamin Maasoumy, Kerstin Port, Katja Deterding, Christoph Höner zu Siederdissen, Antoaneta A. Markova, Magdalena Rogalska-Taranta, Michael P. Manns, Heiner Wedemeyer, Markus Cornberg, Limited effectiveness and safety profile of protease inhibitor-based triple therapy against chronic hepatitis C in a real-world cohort with a high proportion of advanced liver disease, European Journal of Gastroenterology & Hepatology, 2014, 26, 8, 836

    CrossRef

  6. 6
    Ivan Gentile, Antonio Riccardo Buonomo, Guglielmo Borgia, Ombitasvir: a potent pan-genotypic inhibitor of NS5A for the treatment of hepatitis C virus infection, Expert Review of Anti-infective Therapy, 2014, 12, 9, 1033

    CrossRef

  7. 7
    Tae Hun Kim, June Sung Lee, Recent Advancement in the Treatment of Chronic Hepatitis C, Korean Journal of Medicine, 2014, 86, 5, 563

    CrossRef

  8. 8
    Christoph Höner zu Siederdissen, Markus Cornberg, Sofosbuvir for the treatment of patients with genotype 2 or 3 chronic hepatitis C virus infection, Clinical Investigation, 2014, 4, 4, 361

    CrossRef

  9. 9
    Andrew J Muir, The Rapid Evolution of Treatment Strategies for Hepatitis C, The American Journal of Gastroenterology, 2014, 109, 5, 628

    CrossRef

  10. 10
    Parth J Parekh, Mitchell L Shiffman, The role of interferon in the new era of hepatitis C treatments, Expert Review of Gastroenterology & Hepatology, 2014, 8, 6, 649

    CrossRef

  11. 11
    Jacqueline C.M. Paterson, Michael H. Miller, John F. Dillon, Update on the treatment of hepatitis C genotypes 2–6, Current Opinion in Infectious Diseases, 2014, 27, 6, 540

    CrossRef